218 related articles for article (PubMed ID: 37189027)
1. A comprehensive analysis of different types of databases reveals that CDH1 mRNA and E-cadherin protein are not downregulated in most carcinoma tissues and carcinoma cell lines.
Sicairos B; Alam S; Du Y
BMC Cancer; 2023 May; 23(1):441. PubMed ID: 37189027
[TBL] [Abstract][Full Text] [Related]
2. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.
Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA
Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
5. [Expression of E-cadherin and beta1-integrin mRNA in endometrial cancer].
Wójcik-Krowiranda K; Forma E; Zaczek A; Bryś M; Anna MK; Bieńkiewicz A
Ginekol Pol; 2013 Nov; 84(11):910-4. PubMed ID: 24455846
[TBL] [Abstract][Full Text] [Related]
6. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
7. Control of
Osman IO; Garrec C; de Souza GAP; Zarubica A; Belhaouari DB; Baudoin JP; Lepidi H; Mege JL; Malissen B; Scola B; Devaux CA
Front Cell Infect Microbiol; 2022; 12():798767. PubMed ID: 35601094
[TBL] [Abstract][Full Text] [Related]
8. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
Olson A; Le V; Aldahl J; Yu EJ; Hooker E; He Y; Lee DH; Kim WK; Cardiff RD; Geradts J; Sun Z
PLoS Genet; 2019 Oct; 15(10):e1008451. PubMed ID: 31658259
[TBL] [Abstract][Full Text] [Related]
9. Downregulated vimentin and upregulated E-cadherin in T1 stage non-small-cell lung cancer: does it suggest a mesenchymal-epithelial transition?
Luo T; Wang L; Wu P; Gong W; Chen W; Zhao H; Zheng Z
Neoplasma; 2017; 64(5):693-699. PubMed ID: 28592120
[TBL] [Abstract][Full Text] [Related]
10. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer.
Xie D; Chen Y; Wan X; Li J; Pei Q; Luo Y; Liu J; Ye T
Front Endocrinol (Lausanne); 2022; 13():916469. PubMed ID: 35784532
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression.
Zheng X; Pan Y; Chen X; Xia S; Hu Y; Zhou Y; Zhang J
Cancer Sci; 2021 Jan; 112(1):117-132. PubMed ID: 33063904
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer.
Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Mizoguchi K; Sagawa H; Okubo T; Takeyama H
World J Surg Oncol; 2016 Sep; 14(1):240. PubMed ID: 27600761
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D
J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301
[TBL] [Abstract][Full Text] [Related]
14. CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression.
Xie J; Feng Y; Lin T; Huang XY; Gan RH; Zhao Y; Su BH; Ding LC; She L; Chen J; Lin LS; Lin X; Zheng DL; Lu YG
Oncotarget; 2016 Dec; 7(50):82961-82971. PubMed ID: 27783992
[TBL] [Abstract][Full Text] [Related]
15. LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice.
Ter Steege EJ; Sijnesael T; Enserink L; Klarenbeek S; Haakma WE; Bakker ERM; Derksen PWB
Neoplasia; 2023 Jan; 35():100844. PubMed ID: 36371908
[TBL] [Abstract][Full Text] [Related]
16. ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target.
Erfani M; Zamani M; Hosseini SY; Mostafavi-Pour Z; Shafiee SM; Saeidnia M; Mokarram P
Mol Biol Rep; 2021 Oct; 48(10):6749-6756. PubMed ID: 34424445
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas.
Kroepil F; Fluegen G; Totikov Z; Baldus SE; Vay C; Schauer M; Topp SA; Esch JS; Knoefel WT; Stoecklein NH
PLoS One; 2012; 7(9):e46665. PubMed ID: 23029563
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas.
Qian ZR; Sano T; Yoshimoto K; Asa SL; Yamada S; Mizusawa N; Kudo E
Mod Pathol; 2007 Dec; 20(12):1269-77. PubMed ID: 17873891
[TBL] [Abstract][Full Text] [Related]
19. Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?
Karch I; Schipper E; Christgen H; Kreipe H; Lehmann U; Christgen M
PLoS One; 2013; 8(8):e73062. PubMed ID: 24023670
[TBL] [Abstract][Full Text] [Related]
20. Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.
Buehler D; Hardin H; Shan W; Montemayor-Garcia C; Rush PS; Asioli S; Chen H; Lloyd RV
Mod Pathol; 2013 Jan; 26(1):54-61. PubMed ID: 22899291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
